Navigation Links
Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
Date:4/10/2012

WASHINGTON, April 10, 2012 /PRNewswire-USNewswire/ -- Prioritized funding for biomedical research and the healthcare workforce is critical to our nation's economy and wellbeing, Dr. Steven A. Wartman, president and CEO of the Association of Academic Health Centers (AAHC), told the House Committee on Appropriations' Subcommittee on Labor, Health and Human Services, Education and Related Agencies in a submitted written statement.  Wartman urged policymakers to "continue to demonstrate bipartisan commitment to a strong economy and improved health" as they deliberate pertinent funding measures.

Wartman presented findings and recommendations to the Subcommittee on the economic impact of biomedical research, noting that "in order to preserve the many benefits of a thriving research community, including American competitiveness abroad, we must continue to invest in the growth of the sector.  Sustained growth of funding for the National Institutes of Health (NIH) is crucial to this endeavor." 

Wartman also argued that access to health care is being threatened by an increasingly inadequate health professions workforce and called on Congress to sufficiently "fund workforce development programs at the Health Resources and Services Administration" and, at a minimum, "maintain the current funding scheme and number of slots for graduate medical education."  He also called for $3 million in appropriations for the National Health Care Workforce Commission, noting the importance of "a comprehensive national strategic vision for health workforce policy and planning" because "the nation's health workforce cannot meet the current needs in underserved areas and the future needs of an aging population."  The Commission is the "right body to develop that vision," according to Wartman.

Recognizing the fiscal pressures of this current environment, Wartman told legislators that "investing in the nation's biomedical research enterprise and in the development of a robust health workforce is critical to ensure a stronger economy and healthier population in the future" adding that the AAHC looks forward to working with Congress to prioritize spending in FY2013 "and into the future."

The AAHC, representing more than 100 academic health centers nationwide, is a national non-profit association dedicated to advancing the nation's health and well-being through the vigorous leadership of academic health centers.   Testimony and information on the workforce is available at: www.aahcdc.org.


'/>"/>
SOURCE Association of Academic Health Centers
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
2. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
3. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
4. FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome
5. AlphaVax Announces Nomination for 2012 Vaccine Industry Excellence Award
6. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
7. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
8. Dr. Alan Gaby to Present Nutritional Medicine Updates in a Nationwide Tour
9. Groundbreaking National Program to Reverse Obesity Expands to 50 Locations
10. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
11. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):